Connective tissue disease following anti-epileptic therapy.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D003095:Collagen Diseases / Q000139:chemically induced*; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D005260:Female; D006801:Humans; D007841:Latex Fixation Tests; D009504:Neutrophils; D010076:Oxazepam / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011239:Prednisolone / Q000627:therapeutic use; D011324:Primidone / Q000009:adverse effects
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D010076:Oxazepam; D011239:Prednisolone